【4502】武田薬品工業 : Takeda Receives FDA Approval for Three New Type 2 Diabetes Therapies, NESINA and Fixed-Dose Combinations OSENI and KAZANO

Takeda Receives FDA Approval for Three New Type 2 Diabetes Therapies, NESINA and Fixed-Dose Combinations OSENI and KAZANO

出所:株経通信(株式会社みんかぶ)
PDFをダウンロード